Abstract
BackgroundDespite concerns that patients with autoimmune hepatitis (AIH) may be at increased risk of adverse outcomes from COVID-19 due to use of immunosuppression, the impact of SARS-CoV-2 infection on this...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
